Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
Clinical trial NCT03496467 · COMPLETED
Trial details
- NCT number
- NCT03496467
- Sponsor
- Mati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2018-12-17
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.